Performance Enhancement and Adverse Consequences of MDMA

References

• Baumgarten , H G and Lachenmayer , L . 2004 . Serotonin neurotoxinspast and present . Neurotox Res , 6 : 589 – 614 .
   PubMed Web of Science ®Google Scholar
• Peroutka , S J . 1987 . Incidence of recreational use of 3,4-methylenedimethoxymethamphetamine (MDMA, “ecstasy”) on an undergraduate campus . N Engl J Med , 317 : 1542 – 3 .
   PubMed Web of Science ®Google Scholar
• Iannone , M , Bulotta , S , Paolino , D , Zito , M C , Gratteri , S , Costanzo , F S and Rotiroti , D . 2006 . Electrocortical effects of MDMA are potentiated by acoustic stimulation in rats . BMC Neurosci , 7 : 13
   PubMed Web of Science ®Google Scholar
• Schifano , F , Corkery , J , Deluca , P , Oyefeso , A and Ghodse , A H . 2006 . Ecstasy (MDMA, MDA, MDEA, MBDB) consumption, seizures, related offences, prices, dosage levels and deaths in the UK (1994–2003) . J Psychopharmacol , 20 : 456 – 63 .
   PubMed Web of Science ®Google Scholar
• Cami , J , Farre , M , Mas , M , Roset , P N , Poudevida , S , Mas , A , San , L and de la Torre , R . 2000 . Human pharmacology of 3,4-methylenedioxymethamphetamine (“ecstasy”): psychomotor performance and subjective effects . J Clin Psychopharmacol , 20 : 455 – 66 .
   PubMed Web of Science ®Google Scholar
• de la Torre , R , Farre , M , Roset , P N , Pizarro , N , Abanades , S , Segura , M , Segura , J and Cami , J . 2004 . Human pharmacology of MDMA: pharmacokinetics, metabolism, and disposition . Ther Drug Monit , 26 : 137 – 44 .
   PubMed Web of Science ®Google Scholar
• Britt , G C and McCance-Katz , E F . 2005 . A brief overview of the clinical pharmacology of “club drugs.” Subst Use Misuse , 40 : 1189 – 201 .
   PubMed Web of Science ®Google Scholar
• Rodgers , J , Buchanan , T , Pearson , C , Parrott , A C , Ling , J , Hefferman , T M and Scholey , A B . 2006 . Differential experiences of the psychobiological sequelae of ecstasy use: quantitative and qualitative data from an internet study . J Psychopharmacol , 20 : 437 – 46 .
   PubMed Web of Science ®Google Scholar
• Gold , M , Tabrah , H and Frost-Pineda , K . 2001 . Psychopharmacology of MDMA (Ecstasy) . Psychiatric Annals , 31 : 675 – 81 .
   Web of Science ®Google Scholar
• Able , J A , Gudelsky , G A , Vorhees , C V and Williams , M T . 2006 . 3,4-Methylenedioxymethamphetamine in adult rats produces deficits in path integration and spatial reference memory . Biol Psychiatry , 59 ( 12 ) : 1219 – 26 .
   PubMed Web of Science ®Google Scholar
• Cadoni , C , Solinas , M , Pisanu , A , Zernig , G , Acquas , E and Di Chiara , G . 2005 . Effect of 3,4-methylendioxymethamphetamine (MDMA, “ecstasy”) on dopamine transmission in the nucleus accumbens shell and core . Brain Res , 1055 : 143 – 8 .
   PubMed Web of Science ®Google Scholar
• Mortelmans , L J , Bogaerts , P J , Hellemans , S , Volders , W and Van Rossom , P . 2005 . Spontaneous pneumomediastinum and myocarditis following Ecstasy use: a case report . Eur J Emerg Med , 12 : 36 – 8 .
   PubMed Web of Science ®Google Scholar
• Curran , H V and Robjant , K . 2006 . Eating attitudes, weight concerns and beliefs about drug effects in women who use ecstasy . J Psychopharmacol , 20 : 425 – 31 .
   PubMed Web of Science ®Google Scholar
• Schmidt , C J . 1987 . Neurotoxicity of the psychedelic amphetamine, methylenedioxymethamphetamine . J Pharmacol Exp Ther , 240 : 1 – 7 .
   PubMed Web of Science ®Google Scholar
• Green , A R , Cross , A J and Goodwin , G M . 1995 . Review of the pharmacology and clinical pharmacology of 3,4- methylenedioxymethamphetamine (MDMA or “Ecstasy”) . Psychopharmacology (Berl) , 119 : 247 – 60 .
   PubMed Web of Science ®Google Scholar
• Green , A R , Mechan , A O , Elliott , J M , O'Shea , E and Colado , M I . 2003 . The pharmacology and clinical pharmacology of 3,4-methylenedioxymethamphetamine (MDMA, “ecstasy”) . Pharmacol Rev , 55 : 463 – 508 .
   PubMed Web of Science ®Google Scholar
• Fone , K C , Beckett , S R , Topham , I A , Swettenham , J , Ball , M and Maddocks , L . 2002 . Long-term changes in social interaction and reward following repeated MDMA administration to adolescent rats without accompanying serotonergic neurotoxicity . Psychopharmacology (Berl) , 159 : 437 – 44 .
   PubMed Web of Science ®Google Scholar
• Shulgin , A T . 1986 . The background and chemistry of MDMA . J Psychoactive Drugs , 18 : 291 – 304 .
   PubMed Web of Science ®Google Scholar
• Gold , M and Tabrah , H . 2000 . Update on the ecstasy epidemic . Addictions Nursing , 12 : 133 – 43 .
   Google Scholar
• Climko , R P , Roehrich , H , Sweeney , D R and Al-Razi , J . 1986 . Ecstacy: a review of MDMA and MDA . Int J Psychiatry Med , 16 : 359 – 72 .
   PubMed Web of Science ®Google Scholar
• Kalant , H . 2001 . The pharmacology and toxicology of “ecstasy” (MDMA) and related drugs . Cmaj , 165 : 917 – 28 .
   PubMed Web of Science ®Google Scholar
• Greer , G R and Tolbert , R . 1998 . A method of conducting therapeutic sessions with MDMA . J Psychoactive Drugs , 30 : 371 – 9 .
   PubMed Web of Science ®Google Scholar
• Volkow , N . 2005 . MDMA (Ecstasy) Abuse , Research Report Series Vol. 2006 , Rockville, MD : National Institute on Drug Abuse .
   Google Scholar
• NIDA . National Institute on Drug Abuse http://www.drugabuse.gov/clubalert/clubdrugalert.html, 2003.
   Google Scholar
• Parrott , A C and Lasky , J . 1998 . Ecstasy (MDMA) effects upon mood and cognition: before, during and after a Saturday night dance . Psychopharmacology (Berl) , 139 : 261 – 8 .
   PubMed Web of Science ®Google Scholar
• Theune , M , Esser , W , Druschky , K F , Interschick , E and Patscheke , H . 1999 . [Grand mal series after Ecstasy abuse] . Nervenarzt , 70 : 1094 – 7 .
   PubMed Web of Science ®Google Scholar
• Goldberger , B and Gold , M . 2002 . Ecstasy deaths in the state of Florida: a postmortem analysis . Bio Psychiatry , 51 : 557
   Web of Science ®Google Scholar
• Cole , J C , Sumnall , H R and Wagstaff , G F . 2002 . What is a dose of ecstasy? . J Psychopharmacol , 16 : 189 – 90 .
   PubMed Web of Science ®Google Scholar
• Bedi , G and Redman , J . 2006 . Self-reported ecstasy use: the impact of assessment method on dosage estimates in recreational users . J Psychopharmacol , 20 : 432 – 6 .
   PubMed Web of Science ®Google Scholar
• Schifano , F . 2001 . New trends in drug addiction: synthetic drugs. Epidemiological, clinical and preventive issues . Epidemiol Psichiatr Soc , 10 : 63 – 70 .
   PubMedGoogle Scholar
• Morton , J . 2005 . Ecstasy: pharmacology and neurotoxicity . Curr Opin Pharmacol , 5 : 79 – 86 .
   PubMed Web of Science ®Google Scholar
• Schifano , F . 2000 . Potential human neurotoxicity of MDMA (‘Ecstasy’): subjective self-reports, evidence from an Italian drug addiction centre and clinical case studies . Neuropsychobiology , 42 : 25 – 33 .
   PubMed Web of Science ®Google Scholar
• Winstock , A R , Griffiths , P and Stewart , D . 2001 . Drugs and the dance music scene: a survey of current drug use patterns among a sample of dance music enthusiasts in the UK . Drug Alcohol Depend , 64 : 9 – 17 .
   PubMed Web of Science ®Google Scholar
• Patel , M M , Wright , D W , Ratcliff , J J and Miller , M A . 2004 . Shedding new light on the “safe” club drug: methylenedioxymethamphetamine (ecstasy)-related fatalities . Acad Emerg Med , 11 : 208 – 10 .
   PubMed Web of Science ®Google Scholar
• Valentine , G . 2002 . MDMA and Ecstasy . Psychiatric Times , 19 ( 2 )
   Google Scholar
• EMCDDA . 44 – 52 . European Monitoring Centre for Drugs and Drug Addiction The 2005 Annual Report on the state of the drugs problem in Europe European Monitoring Centre for Drugs and Drug Addiction http://www.emcdda.europa.eu/.Luxembourg: European Monitoring Centre for Drugs and Drug Addiction, 2005
   Google Scholar
• Agency, US. DE . MDMA (Ecstasy) Factsheet , Vol. 2006 , United States Drug Enforcement Agency .
   Google Scholar
• Young , F L . In the matter of MDMA scheduling Docket No. 84–48 Opinion and Recommended Ruling, Findings of Fact, Conclusions of Law and Decision of Administrative Law Jude on Issues two through Seven, Vol. 2006: United States Department of Justice, 1986.
   Google Scholar
• Johnston , L , O'Malley , P M , Bachman , J G and Schulenbery , J E . 2005 . “ Monitoring the future national survey results on drug use, 1975–2004 ” . In Volume II: College students and adults ages 19–45 , 1 – 278 . Bethesda, MD : National Institue on Drug Abuse .
   Google Scholar
• NHSDA . National Household Survey on Drug Abuse-SAMHSA Factsheet: http://www.whitehousedrugpolicy.gov/drugfact/nhsda01.html,. 2001.
   Google Scholar
• Banken , J A . 2004 . Drug abuse trends among youth in the United States . Ann N Y Acad Sci , 1025 : 465 – 71 .
   PubMed Web of Science ®Google Scholar
• MTF. Monitoring the Future. National Results on Adolescent Drug use. http://www.monitoringthefuture.org/pubs/monographs/overview2004.pdf: National Institute on Drug Abuse, 2004: 1–72.
   Google Scholar
• DAWN. Drug Abuse Warning Network (DAWN) http://dawninfo.samhsa.gov/. 2003.
   Google Scholar
• 2006 . Services, USDo HH. Ecstasy, other club drugs & other Hallucinogens Vol. 2006 , SAMSHA
   Google Scholar
• Rochester , J A and Kirchner , J T . 1999 . Ecstasy (3,4-methylenedioxymethamphetamine): history, neurochemistry, and toxicology . J Am Board Fam Pract , 12 : 137 – 42 .
   PubMedGoogle Scholar
• Lyles , J and Cadet , J L . 2003 . Methylenedioxymethamphetamine (MDMA, Ecstasy) neurotoxicity: cellular and molecular mechanisms . Brain Res Brain Res Rev , 42 : 155 – 68 .
   PubMedGoogle Scholar
• de la Torre , R , Farre , M , Ortuno , J , Mas , M , Brenneisen , R , Roset , P N , Segura , J and Cami , J . 2000 . Non-linear pharmacokinetics of MDMA (‘ecstasy’) in humans . Br J Clin Pharmacol , 49 : 104 – 9 .
   PubMed Web of Science ®Google Scholar
• Maurer , H H , Bickeboeller-Friedrich , J , Kraemer , T and Peters , F T . 2000 . Toxicokinetics and analytical toxicology of amphetamine-derived designer drugs (‘Ecstasy’) . Toxicol Lett , 112–113 : 133 – 42 .
   PubMed Web of Science ®Google Scholar
• Wu , D , Otton , S V , Inaba , T , Kalow , W and Sellers , E M . 1997 . Interactions of amphetamine analogs with human liver CYP2D6 . Biochem Pharmacol , 53 : 1605 – 12 .
   PubMed Web of Science ®Google Scholar
• Tucker , G T , Lennard , M S , Ellis , S W , Woods , H F , Cho , A K , Lin , L Y , Hiratsuka , A , Schmitz , D A and Chu , T Y . 1994 . The demethylenation of methylenedioxymethamphetamine (“ecstasy”) by debrisoquine hydroxylase (CYP2D6) . Biochem Pharmacol , 47 : 1151 – 6 .
   PubMed Web of Science ®Google Scholar
• Gonzalez , F J and Meyer , U A . 1991 . Molecular genetics of the debrisoquin-sparteine polymorphism . Clin Pharmacol Ther , 50 : 233 – 8 .
   PubMed Web of Science ®Google Scholar
• Mas , M , Farre , M , dela Torre , R , Roset , P N , Ortuno , J , Segura , J and Cami , J . 1999 . Cardiovascular and neuroendocrine effects and pharmacokinetics of 3, 4-methylenedioxy-methamphetamine in humans . J Pharmacol Exp Ther , 290 : 136 – 45 .
   PubMed Web of Science ®Google Scholar
• Henry , J A , Fallon , J K , Kicman , A T , Hutt , A J , Cowan , D A and Forsling , M . 1998 . Low-dose MDMA (“ecstasy”) induces vasopressin secretion . Lancet , 351 : 1784
   PubMed Web of Science ®Google Scholar
• Verebey , K , Alrazi , J and Jaffe , J H . 1988 . The complications of ‘ecstasy’ (MDMA) . JAMA , 259 : 1649 – 50 .
   PubMed Web of Science ®Google Scholar
• Schechter , M D . 1987 . MDMA as a discriminative stimulus: isomeric comparisons . Pharmacol Biochem Behav , 27 : 41 – 4 .
   PubMed Web of Science ®Google Scholar
• Baker , L E and Taylor , M M . 1997 . Assessment of the MDA and MDMA optical isomers in a stimulant-hallucinogen discrimination . Pharmacol Biochem Behav , 57 : 737 – 48 .
   PubMed Web of Science ®Google Scholar
• Vereby , K and Gold , M S . 1988 . From coca leaves to crack: The effects of dose and routes of adminstration in abuse liability . Psychiatric Annals , 18 : 513 – 20 .
   Web of Science ®Google Scholar
• Brookhuis , K A , de Waard , D and Samyn , N . 2004 . Effects of MDMA (ecstasy), and multiple drugs use on (simulated) driving performance and traffic safety . Psychopharmacology (Berl) , 173 : 440 – 5 .
   PubMed Web of Science ®Google Scholar
• Sherlock , K , Wolff , K , Hay , A W and Conner , M . 1999 . Analysis of illicit ecstasy tablets: implications for clinical management in the accident and emergency department . J Accid Emerg Med , 16 : 194 – 7 .
   PubMedGoogle Scholar
• Cohen , R S . 1995 . Subjective reports on the effects of the MDMA (‘ecstasy’) experience in humans . Prog Neuropsychopharmacol Biol Psychiatry , 19 : 1137 – 45 .
   PubMed Web of Science ®Google Scholar
• Christopherson , A . 2000 . Amphetamine designer drugs- an overview and epidemiology . Toxicol Lett , 12 : 127 – 31 .
   Google Scholar
• Vollenweider , F X , Gamma , A , Liechti , M and Huber , T . 1998 . Psychological and cardiovascular effects and short-term sequelae of MDMA (“ecstasy”) in MDMA-naive healthy volunteers . Neuropsychopharmacology , 19 : 241 – 51 .
   PubMed Web of Science ®Google Scholar
• Buffum , J and Moser , C . 1986 . MDMA and human sexual function . J Psychoactive Drugs , 18 : 355 – 9 .
   PubMed Web of Science ®Google Scholar
• Hutton , F . 2004 . Up for it, mad for it? Women, drug use and participation in club scenes . Health, Risk and Society , 6 : 223 – 37 .
   Web of Science ®Google Scholar
• Murphy , P N , Wareing , M and Fisk , J . 2006 . Users' perceptions of the risks and effects of taking ecstasy (MDMA): a questionnaire study . J Psychopharmacol , 20 : 447 – 55 .
   PubMed Web of Science ®Google Scholar
• Mter Bogt , T F and Engels , R C . 2005 . “Partying” hard: party style, motives for and effects of MDMA use at rave parties . Subst Use Misuse , 40 : 1479 – 502 .
   PubMed Web of Science ®Google Scholar
• Levy , K B , O'Grady , K E , Wish , E D and Arria , A M . 2005 . An in-depth qualitative examination of the ecstasy experience: results of a focus group with ecstasy-using college students . Subst Use Misuse , 40 : 1427 – 41 .
   PubMed Web of Science ®Google Scholar
• Quednow , B B , Kuhn , K U , Hoppe , C , Westheide , J , Maier , W , Daum , I and Wagner , M . 2006 . Elevated impulsivity and impaired decision-making cognition in heavy users of MDMA (“Ecstasy”) . Psychopharmacology (Berl) , : 1 – 14 .
   Web of Science ®Google Scholar
• Piper , B J and Meyer , J S . 2004 . Memory deficit and reduced anxiety in young adult rats given repeated intermittent MDMA treatment during the periadolescent period . Pharmacol Biochem Behav , 79 : 723 – 31 .
   PubMed Web of Science ®Google Scholar
• McCardle , K , Luebbers , S , Carter , J D , Croft , R J and Stough , C . 2004 . Chronic MDMA (ecstasy) use, cognition and mood . Psychopharmacology (Berl) , 173 : 434 – 9 .
   PubMed Web of Science ®Google Scholar
• Iwersen , S and Schmoldt , A . 1996 . Two very different fatal cases associated with the use of methylenedioxyethylamphetamine (MDEA): Eve as deadly as Adam . J Toxicol Clin Toxicol , 34 : 241 – 4 .
   PubMed Web of Science ®Google Scholar
• Grob , C S , Bravo , G L , Walsh , R N and Liester , M B . 1992 . The MDMA-neurotoxicity controversy: implications for clinical research with novel psychoactive drugs . J Nerv Ment Dis , 180 : 355 – 6 .
   PubMed Web of Science ®Google Scholar
• Verheyden , S L , Henry , J A and Curran , H V . 2003 . Acute, sub-acute and long-term subjective consequences of ‘ecstasy’ (MDMA) consumption in 430 regular users . Hum Psychopharmacol , 18 : 507 – 17 .
   PubMed Web of Science ®Google Scholar
• Verheyden , S L , Hadfield , J , Calin , T and Curran , H V . 2002 . Sub-acute effects of MDMA (+/- 3,4-methylenedioxy-methamphetamine, “ecstasy”) on mood: evidence of gender differences . Psychopharmacology (Berl) , 161 : 23 – 31 .
   PubMed Web of Science ®Google Scholar
• Siegel , R K . 1986 . MDMA. Nonmedical use and intoxication . J Psychoactive Drugs , 18 : 349 – 54 .
   PubMed Web of Science ®Google Scholar
• Henry , J A , Jeffreys , K J and Dawling , S . 1992 . Toxicity and deaths from 3,4-methylenedioxymethamphetamine (“ecstasy”) . Lancet , 340 : 384 – 7 .
   PubMed Web of Science ®Google Scholar
• Dykhuizen , R S , Brunt , P W , Atkinson , P , Simpson , J G and Smith , C C . 1995 . Ecstasy induced hepatitis mimicking viral hepatitis . Gut , 36 : 939 – 41 .
   PubMed Web of Science ®Google Scholar
• Patel , M M , Belson , M G , Longwater , A B , Olson , K R and Miller , M A . 2005 . Methylenedioxymethamphetamine (ecstasy)-related hyperthermia . J Emerg Med , 29 : 451 – 4 .
   PubMed Web of Science ®Google Scholar
• Capela , J P , Meisel , A , Abreu , A R , Branco , P S , Ferreira , L M , Lobo , A M , Remiao , F , Bastos , M L and Carvalho , F . 2006 . Neurotoxicity of Ecstasy metabolites in rat cortical neurons, and influence of hyperthermia . J Pharmacol Exp Ther , 316 : 53 – 61 .
   PubMed Web of Science ®Google Scholar
• Nutt , D J . 2006 . A tale of two Es . J Psychopharmacol , 20 : 315 – 7 .
   PubMed Web of Science ®Google Scholar
• Dafters , R I . 1994 . Effect of ambient temperature on hyperthermia and hyperkinesis induced by 3,4-methylenedioxymethamphetamine (MDMA or “ecstasy”) in rats . Psychopharmacology (Berl) , 114 : 505 – 8 .
   PubMed Web of Science ®Google Scholar
• Bogen , I L , Haug , K H , Myhre , O and Fonnum , F . 2003 . Shortand long-term effects of MDMA (“ecstasy”) on synaptosomal and vesicular uptake of neurotransmitters in vitro and ex vivo . Neurochem Int , 43 : 393 – 400 .
   PubMed Web of Science ®Google Scholar
• Dafters , R I . 1995 . Hyperthermia following MDMA administration in rats: effects of ambient temperature, water consumption, and chronic dosing . Physiol Behav , 58 : 877 – 82 .
   PubMed Web of Science ®Google Scholar
• Taffe , M A , Lay , C C , Von Huben , S N , Davis , S A , Crean , R D and Katner , S N . 2006 . Hyperthermia induced by 3,4-methylenedioxymethamphetamine in unrestrained rhesus monkeys . Drug Alcohol Depend , 82 : 276 – 81 .
   PubMed Web of Science ®Google Scholar
• Freedman , R R , Johanson , C E and Tancer , M E . 2005 . Thermoregulatory effects of 3,4-methylenedioxymethamphetamine (MDMA) in humans . Psychopharmacology (Berl) , 183 : 248 – 56 .
   PubMed Web of Science ®Google Scholar
• Fallon , J K , Shah , D , Kicman , A T , Hutt , A J , Henry , J A , Cowan , D A and Forsling , M . 2002 . Action of MDMA (ecstasy) and its metabolites on arginine vasopressin release . Ann N Y Acad Sci , 965 : 399 – 409 .
   PubMed Web of Science ®Google Scholar
• Forsling , M L , Fallon , J K , Shah , D , Tilbrook , G S , Cowan , D A , Kicman , A T and Hutt , A J . 2002 . The effect of 3,4-methylenedioxymethamphetamine (MDMA, ‘ecstasy’) and its metabolites on neurohypophysial hormone release from the isolated rat hypothalamus . Br J Pharmacol , 135 : 649 – 56 .
   PubMed Web of Science ®Google Scholar
• Soar , K , Turner , J J and Parrott , A C . 2001 . Psychiatric disorders in Ecstasy (MDMA) users: a literature review focusing on personal predisposition and drug history . Hum Psychopharmacol , 16 : 641 – 5 .
   PubMed Web of Science ®Google Scholar
• Thomasius , R , Petersen , K U , Zapletalova , P , Wartberg , L , Zeichner , D and Schmoldt , A . 2005 . Mental disorders in current and former heavy ecstasy (MDMA) users . Addiction , 100 : 1310 – 9 .
   PubMed Web of Science ®Google Scholar
• Morgan , M J , McFi , L , Fleetwood , H and Robinson , J A . 2002 . Ecstasy (MDMA): are the psychological problems associated with its use reversed by prolonged abstinence? . Psychopharmacology (Berl) , 159 : 294 – 303 .
   PubMed Web of Science ®Google Scholar
• Reay , J L , Hamilton , C , Kennedy , D O and Scholey , A B . 2006 . MDMA polydrug users show process-specific central executive impairments coupled with impaired social and emotional judgement processes . J Psychopharmacol , 20 : 385 – 8 .
   PubMed Web of Science ®Google Scholar
• Parrott , A C . 2004 . Is ecstasy MDMA? A review of the proportion of ecstasy tablets containing MDMA, their dosage levels, and the changing perceptions of purity . Psychopharmacology (Berl) , 173 : 234 – 41 .
   PubMed Web of Science ®Google Scholar
• Dughiero , G , Schifano , F and Forza , G . 2001 . Personality dimensions and psychopathological profiles of Ecstasy users . Hum Psychopharmacol , 16 : 635 – 9 .
   PubMed Web of Science ®Google Scholar
• Herkov , M , Gold , M and Frost-Pineda , K . 2001 . Neuropsychological consequences of MDMA . Biol Psychiatry , 49 : 1S – 176S .
   PubMed Web of Science ®Google Scholar
• Parrott , A C . 2001 . Human psychopharmacology of Ecstasy (MDMA): a review of 15 years of empirical research . Hum Psychopharmacol , 16 : 557 – 77 .
   PubMed Web of Science ®Google Scholar
• Guillot , C and Greenway , D . 2006 . Recreational ecstasy use and depression . J Psychopharmacol , 20 : 411 – 6 .
   PubMed Web of Science ®Google Scholar
• Jansen , K L . 1999 . Ecstasy (MDMA) dependence . Drug Alcohol Depend , 53 : 121 – 4 .
   PubMed Web of Science ®Google Scholar
• Schifano , F , Di Furia , L , Forza , G , Minicuci , N and Bricolo , R . 1998 . MDMA (‘ecstasy’) consumption in the context of polydrug abuse: a report on 150 patients . Drug Alcohol Depend , 52 : 85 – 90 .
   PubMed Web of Science ®Google Scholar
• Ricaurte , G A and McCann , U D . 2001 . Assessing long-term effects of MDMA (Ecstasy) . Lancet , 358 : 1831 – 2 .
   PubMed Web of Science ®Google Scholar
• Commins , D L , Vosmer , G , Virus , R M , Woolverton , W L , Schuster , C R and Seiden , L S . 1987 . Biochemical and histological evidence that methylenedioxymethylamphetamine (MDMA) is toxic to neurons in the rat brain . J Pharmacol Exp Ther , 241 : 338 – 45 .
   PubMed Web of Science ®Google Scholar
• O'Hearn , E , Battaglia , G , De Souza , E B , Kuhar , M J and Molliver , M E . 1988 . Methylenedioxyamphetamine (MDA) and methylenedioxymethamphetamine (MDMA) cause selective ablation of serotonergic axon terminals in forebrain: immunocytochemical evidence for neurotoxicity . J Neurosci , 8 : 2788 – 803 .
   PubMed Web of Science ®Google Scholar
• Green , A R and Goodwin , G M . 1996 . Ecstasy and neurodegeneration . BMI , 312 : 1493 – 4 .
   PubMed Web of Science ®Google Scholar
• Salzmann , J , Marie-Claire , C and Noble , F . 2004 . Acute and long-term effects of ecstasy . Presse Med , 33 : 24 – 32 .
   PubMed Web of Science ®Google Scholar
• Jimenez , A , Jorda , E G , Verdaguer , E , Pubill , D , Sureda , F X , Canudas , A M , Escubedo , E , Camarasa , J , Camins , A and Pallas , M . 2004 . Neurotoxicity of amphetamine derivatives is mediated by caspase pathway activation in rat cerebellar granule cells . Toxicol Appl Pharmacol , 196 : 223 – 34 .
   PubMed Web of Science ®Google Scholar
• Steele , T D , Nichols , D E and Yim , G K . 1987 . Stereochemical effects of 3,4-methylenedioxymethamphetamine (MDMA) and related amphetamine derivatives on inhibition of uptake of [3H]monoamines into synaptosomes from different regions of rat brain . Biochem Pharmacol , 36 : 2297 – 303 .
   PubMed Web of Science ®Google Scholar
• Battaglia , G , Brooks , B P , Kulsakdinun , C and De Souza , E B . 1988 . Pharmacologic profile of MDMA (3,4-methylenedioxymethamphetamine) at various brain recognition sites . Eur J Pharmacol , 149 : 159 – 63 .
   PubMed Web of Science ®Google Scholar
• Cole , J C and Sumnall , H R . 2003 . The pre-clinical behavioural pharmacology of 3,4-methylenedioxymethamphetamine (MDMA) . Neurosci Biobehav Rev , 27 : 199 – 217 .
   PubMed Web of Science ®Google Scholar
• Bialer , P A . 2002 . Designer drugs in the general hospital . Psychiatr Clin North Am , 25 : 231 – 43 .
   PubMed Web of Science ®Google Scholar
• Thiriet , N , Ladenheim , B , McCoy , M T and Cadet , J L . 2002 . Analysis of ecstasy (MDMA)-induced transcriptional responses in the rat cortex . Faseb J , 16 : 1887 – 94 .
   PubMed Web of Science ®Google Scholar
• Sulzer , D , Sonders , M S , Poulsen , N W and Galli , A . 2005 . Mechanisms of neurotransmitter release by amphetamines: a review . Prog Neurobiol , 75 : 406 – 33 .
   PubMed Web of Science ®Google Scholar
• De Souza , E B , Battaglia , G and Insel , T R . 1990 . Neurotoxic effect of MDMA on brain serotonin neurons: evidence from neurochemical and radioligand binding studies . Ann NY Acad Sci , 600 : 682 – 97 . discussion 697–8.
   PubMed Web of Science ®Google Scholar
• McKenna , D J , Guan , X M and Shulgin , A T . 1991 . 3,4-Methylenedioxyamphetamine (MDA) analogues exhibit differential effects on synaptosomal release of 3H-dopamine and 3H-5-hydroxytryptamine . Pharmacol Biochem Behav , 38 : 505 – 12 .
   PubMed Web of Science ®Google Scholar
• Broening , H W , Bowyer , J F and Slikker , W Jr. 1995 . Agedependent sensitivity of rats to the long-term effects of the serotonergic neurotoxicant (±)-3,4-methylenedioxymethamphetamine (MDMA) correlates with the magnitude of the MDMA-induced thermal response . J Pharmacol Exp Ther , 275 : 325 – 33 .
   PubMed Web of Science ®Google Scholar
• Bai , F , Jones , D C , Lau , S S and Monks , T J . 2001 . Serotonergic neurotoxicity of 3,4-(±)-methylenedioxyamphetamine and 3,4-(±)-methylendioxymethamphetamine (ecstasy) is potentiated by inhibition of gamma-glutamyl transpeptidase . Chem Res Toxicol , 14 : 863 – 70 .
   PubMed Web of Science ®Google Scholar
• Bai , F , Lau , S S and Monks , T J . 1999 . Glutathione and N-acetylcysteine conjugates of alpha-methyldopamine produce serotonergic neurotoxicity: possible role in methylenedioxyamphetamine-mediated neurotoxicity . Chem Res Toxicol , 12 : 1150 – 7 .
   PubMed Web of Science ®Google Scholar
• Hiramatsu , M , Kumagai , Y , Unger , S E and Cho , A K . 1990 . Metabolism of methylenedioxymethamphetamine: formation of dihydroxymethamphetamine and a quinone identified as its glutathione adduct . J Pharmacol Exp Ther , 254 : 521 – 7 .
   PubMed Web of Science ®Google Scholar
• Gudelsky , G A . 1996 . Effect of ascorbate and cysteine on the 3,4-methylenedioxymethamphetamine-induced depletion of brain serotonin . J Neural Transm , 103 : 1397 – 404 .
   PubMed Web of Science ®Google Scholar
• Laviola , G , Adriani , W , Terranova , M L and Gerra , G . 1999 . Psychobiological risk factors for vulnerability to psychostimulants in human adolescents and animal models . Neurosci Biobehav Rev , 23 : 993 – 1010 .
   PubMed Web of Science ®Google Scholar
• Seiden , L S and Sabol , K E . 1996 . Methamphetamine and methylenedioxymethamphetamine neurotoxicity: possible mechanisms of cell destruction . NIDA Res Monogr , 163 : 251 – 76 .
   PubMedGoogle Scholar
• Won , L , Bubula , N and Heller , A . 2002 . Fetal exposure to (±)-methylenedioxymethamphetamine in utero enhances the development and metabolism of serotonergic neurons in three-dimensional reaggregate tissue culture . Brain Res Dev Brain Res , 137 : 67 – 73 .
   PubMedGoogle Scholar
• Tiangco , D A , Lattanzio , F A Jr. , Osgood , C J , Beebe , S J , Kerry , J A and Hargrave , B Y . 2005 . 3,4-Methylenedioxymethamphetamine activates nuclear factor-kappa B, increases intracellular calcium, and modulates gene transcription in rat heart cells . Cardiovasc Toxicol , 5 : 301 – 10 .
   PubMed Web of Science ®Google Scholar
• Hrometz , S L , Brown , A W , Nichols , D E and Sprague , J E . 2004 . 3,4-Methylenedioxymethamphetamine (MDMA, ecstasy)-mediated production of hydrogen peroxide in an in vitro model: the role of dopamine, the serotoninreuptake transporter, and monoamine oxidase-B . Neurosci Lett , 367 : 56 – 9 .
   PubMed Web of Science ®Google Scholar
• Cadet , J L , Jayanthi , S and Deng , X . 2005 . Methamphetamineinduced neuronal apoptosis involves the activation of multiple death pathways . Review. Neurotox Res , 8 : 199 – 206 .
   PubMed Web of Science ®Google Scholar
• Escobedo , I , O'Shea , E , Orio , L , Sanchez , V , Segura , M , de la Torre , R , Farre , M , Green , A R and Colado , M I . 2005 . A comparative study on the acute and long-term effects of MDMA and 3,4-dihydroxymethamphetamine (HHMA) on brain monoamine levels after i.p. or striatal administration in mice . Br J Pharmacol , 144 : 231 – 41 .
   PubMed Web of Science ®Google Scholar
• Mechan , A , Yuan , J , Hatzidimitriou , G , Irvine , R J , McCann , U D and Ricaurte , G A . 2006 . Pharmacokinetic profile of single and repeated oral doses of MDMA in squirrel monkeys: relationship to lasting effects on brain serotonin neurons . Neuropsychopharmacology , 31 : 339 – 50 .
   PubMed Web of Science ®Google Scholar
• Hatzidimitriou , G , McCann , U D and Ricaurte , G A . 1999 . Altered serotonin innervation patterns in the forebrain of monkeys treated with (+/-)3,4-methylenedioxy-methamphetamine seven years previously: factors influencing abnormal recovery . J Neurosci , 19 : 5096 – 107 .
   PubMed Web of Science ®Google Scholar